An archive of ADCC/CDC-enhanced biobetter antibodies developed by Creative Biolabs' state-of-the-art technology platform.
CDC-Enhanced Biobetter is a class of therapeutic biological antibodies modified by Fc. Creative Biolabs' advanced CDC enhancement technology platform enables the production of Fc-engineered therapeutic CDC-enhanced antibodies. More specifically, we enhanced the CDC activity of the antibody by mutating the key amino acids in the Fc region of the antibody, giving it greater binding capacity to complement C1q.
Please search below for your CDC-Enhanced Biobetter antibody of interest. Or contact us directly to tailor a solution to your specific needs.
Biobetter Antibodies Betting on the Future Creative Biolabs Visit
All products and services are for Research Use Only. Do Not use in humans.